ResMed
Tracked across 9 events · 159 articles · First seen Jan 06, 2026 · Last active Aug 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: ResMed is partnering with ŌURA to expand access to sleep health education and care, which is expected to increase its reach and potential customer base for sleep disorder solutions.
May 19, 2026 · 6 articles
Business
Impact: ResMed completed the acquisition of Noctrix Health, expanding its clinical sleep health portfolio and advancing its 2030 strategy. This acquisition is expected to enhance ResMed's market position in sleep disorder treatments.
Jun 01, 2026 · 9 articles
Business
Impact: ResMed announced its plan to release financial and operational results for the fourth quarter of fiscal year 2026 and will host a webcast to discuss these results, which is a routine financial disclosure for the company.
Jun 30, 2026 · 6 articles
Business
Impact: ResMed is the seller, divesting MatrixCare to streamline its portfolio and focus on high-growth sleep and connected care markets, which may enhance long-term value.
Jul 07, 2026 · 8 articles
Business
ResMed announced that Carol Burt will become Lead Director on November 15, 2026, succeeding Ron Taylor, who will retire after more than 21 years of service. Burt has served on the board since 2013 and…
Impact: ResMed announced a routine board leadership transition, appointing Carol Burt as Lead Director. The change is not expected to affect its business or stock price.
Aug 17, 2026 · 6 articles
Business
Impact: ResMed is a market leader in the Sleep Apnea Devices Market, with the largest global share, and has recently acquired VirtuOx and EvoDental to expand its diagnostic and therapy capabilities. ResMed also introduced its AirSense 11 CPAP device to the Indian market.
Jan 06, 2026 · 6 articles
Business
Impact: ResMed, an EcoXpert partner of Schneider Electric, worked with Schneider Electric and XETRA on the infrastructure modernization project for United Kingdom — Homerton Healthcare NHS Foundation Trust, providing technical expertise and ongoing service.
Jun 25, 2026 · 6 articles
Business
Impact: ResMed's holding in Nyxoah passively decreased, crossing the 3% threshold downwards to 1.95% of voting rights.
Jun 17, 2026 · 8 articles
Business
Impact: ResMed was listed as a top loser in the S&P 500, indicating negative performance in a different sector.
May 19, 2026 · 104 articles
60
ResMed appointed Carol BurtResMed appoints Carol Burt...
ERGEN INTELLIGENCE
Track ResMed live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard